Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 151–167 of 167 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01403285	Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma	terminated	Phase 1	6	Immatics Biotechnologies GmbHINDUSTRY	1	May 19, 2014	clinicaltrials
NCT01205334	Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme(COGLI)	terminated	Phase 1 / Phase 2	2	Baylor College of MedicineOTHER	1	Aug 26, 2013	clinicaltrials